Analytical Data
-
Gene name
ACR
- Application
-
Alternative Names
ACR；ACDC；ACRP30；APM1；Adiponectin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P10323
-
Expression Region
20-343aa
-
AA Sequence
KDNATCDGPCGLRFRQNPQGGVRIVGGKAAQHGAWPWMVSLQIFTYNSHRYHTCGGSLLNSRWVLTAAHCFVGKNNVHDWRLVFGAKEITYGNNKPVKAPLQERYVEKIIIHEKYNSATEGNDIALVEITPPISCGRFIGPGCLPHFKAGLPRGSQSCWVAGWGYIEEKAPRPSSILMEARVDLIDLDLCNSTQWYNGRVQPTNVCAGYPVGKIDTCQGDSGGPLMCKDSKESAYVVVGITSWGVGCARAKRPGIYTATWPYLNWIASKIGSNALRMIQSATPPPPTTRPPPIRPPFSHPISAHLPWYFQPPPRPLPPRPPAAQ
-
Molecular Weight
39.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACR recombinant proteins have gained significant attention in the field of biotechnology and medicine due to their potential applications in various therapeutic and industrial processes. ACR, or acyl-CoA receptor, plays a crucial role in lipid metabolism and cellular signaling. Research has shown that manipulating ACR pathways can lead to enhanced metabolic activity, making these proteins valuable in treating metabolic disorders such as obesity and diabetes. Additionally, ACR recombinant proteins are of interest for their ability to modulate inflammation and immune responses, which holds promise for developing novel treatments for autoimmune diseases and other inflammatory conditions. The advances in genetic engineering techniques, such as CRISPR and synthetic biology, have facilitated the production and modification of ACR proteins, making it possible to create variants with improved efficacy and stability. Moreover, the study of ACR proteins has expanded to include their role in cancer biology, where they may influence tumor growth and progression. As researchers continue to explore the multifaceted roles of ACR recombinant proteins, their integration into therapeutic applications and biotechnological innovations looks increasingly promising, representing a frontier in precision medicine and metabolic engineering. Thus, the ongoing research on ACR recombinant proteins not only provides insights into fundamental biological processes but also opens doors for novel therapeutic strategies and applications in the biotech industry.
